Opaganib potentially minimizes likelihood of resistance due to viral mutations by targeting a human cell component involved in viral replication ... Dec 22
US FDA approved for the first-line treatment of adults with malignant pleural mesothelioma that cannot be removed by surgery... Oct 05
Five-year open-label extension study shows patients continued to experience a sustained benefit; Aimovig maintained a consistent safety profile ... Oct 03
The pharma co. believes that FSD201 may have the potential to address the over-exuberant inflammatory response characterized by COVID-19 infection... Oct 02
NeuroRx and Relief Therapeutics establish supply and distribution agreements for RLF-100 (aviptadil) ... Oct 01
Face masks and reusable PPE created using Thermaissance technology Is successfully inactivating coronavirus and pneumonia ... Oct 01
India’s heart care gets a big boost with world’s most clinically validated personal ECG device ... Sep 25
-Advertisements-